Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ALTITUDE trial and dual RAS blockade: the alluring but soft science of the surrogate end point.

× No keyword cloud information.

7 in total

1. Dual RAAS blockade has dual effects on outcome.

Authors: Hiddo J Lambers Heerspink; Dick de Zeeuw
Journal: Nat Rev Endocrinol Date: 2013-03-26 Impact factor: 43.330

Review 2. Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate.

Authors: Sarfaraz Ahmad; Jasmina Varagic; Leanne Groban; Louis J Dell'Italia; Sayaka Nagata; Neal D Kon; Carlos M Ferrario
Journal: Curr Hypertens Rep Date: 2014-05 Impact factor: 5.369

Review 3. Potential approaches to reverse or repair renal fibrosis.

Authors: Desiree Tampe; Michael Zeisberg
Journal: Nat Rev Nephrol Date: 2014-02-11 Impact factor: 28.314

4. Blinding Them With Science? Evidence-Based Medicine as a Barrier to Health Care Value.

Authors: Deborah Korenstein
Journal: J Grad Med Educ Date: 2016-02

Review 5. An evolving story of angiotensin-II-forming pathways in rodents and humans.

Authors: Carlos Maria Ferrario; Sarfaraz Ahmad; Sayaka Nagata; Stephen W Simington; Jasmina Varagic; Neal Kon; Louis Joseph Dell'italia
Journal: Clin Sci (Lond) Date: 2014-04 Impact factor: 6.124

6. The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders.

Authors: Bauke Schievink; Hiddo Lambers Heerspink; Hubert Leufkens; Dick De Zeeuw; Jarno Hoekman
Journal: PLoS One Date: 2014-09-30 Impact factor: 3.240

Review 7. Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence?

Authors: Samir G Mallat
Journal: Cardiovasc Diabetol Date: 2013-07-19 Impact factor: 9.951

7 in total